[Skip to Content]
Plenary Speakers Banner

Plenary sessions at the 2026 World Congress on Pain will feature international experts sharing insights into pain research, treatment, and management. These sessions will engage World Congress attendees by spotlighting critical advances and big-picture themes in pain science.

Yves De Koninck, TBD Ian Gilron, MD, MSc, FRCPC Luke Henderson, PhD Angelika Lampert, MD Neil O’Connell, PhD, MSc, BSc (Hons)
Annina Schmid, PhD, MManipTher Emiko Senba, MD, PhD Saurab Sharma, PhD Laura Simons, PhD Clifford Woolf, MB, BCh, PhD

A Balancing Act: Neuronal Ion Homeostasis and Chronic Pain

Yves De Koninck, PhD, FCAHS, FRSC, examines how chloride dysregulation in spinal sensory neurons disrupts inhibitory control and drives key features of neuropathic pain. He explores how altered synaptic transmission leads to hyperalgesia, allodynia, and spontaneous pain, and considers how targeting chloride homeostasis offers new and unconventional directions for chronic pain therapeutics.

Back to Top >

Yves De Koninck, PhD, FCAHS, FRSC
CERVO Brain Research Centre, Canada

Advances in Research on Combination Therapy for the Management of Pain

Ian Gilron, MD, MSc, FRCPC, reviews the latest evidence on using combination therapies to treat acute and chronic pain. This talk covers how different analgesic medications and modalities can be combined to provide more effective relief than monotherapy. He discusses recent clinical trials guiding optimized multi-modal pain management for conditions ranging from postoperative pain to neuropathic pain.

Back to Top >

Ian Gilron

Ian Gilron, MD, MSc, FRCPC
Queen’s University, Canada

Brain Sites Involved in Endogenous Analgesia

Luke Henderson, PhD, illuminates the brain’s intrinsic pain-suppression pathways (endogenous analgesia) through the lens of neuroimaging. He identifies key brain regions and circuits that dampen pain signals, and discusses how variations in these systems may explain differences in pain tolerance. Understanding these neural mechanisms may inform new therapies that enhance the body’s natural pain control systems.

Back to Top >

Luke Henderson, PhD
University of Sydney, Australia

Bridging Molecules and Mechanisms: Sensory Neurons and Sodium Channels in Neuropathic Pain

Angelika Lampert, MD, will delve into how voltage-gated sodium channels drive pain signaling and how they can be targeted for pain relief. She describes the physiological roles of specific sodium channel subtypes in nerve excitability and neuropathic pain. The presentation also explores the potential of channel-specific therapies and personalized approaches for patients with pain associated with sodium channel dysfunction.

Back to Top >

Angelika Lampert, MD
Uniklinik RWTH Aachen, Germany

Enhancing the Trustworthiness of Pain Research: A Call to Action

Neil O’Connell, PhD, MSc, BSc (Hons), will address the critical issue of scientific rigor and reproducibility in pain research. He outlines challenges posed by bias and irreproducibility in current studies and introduces initiatives (such as the ENTRUST-PE project) aimed at improving research credibility. This lecture calls on the pain research community to adopt better practices that enhance the quality and impact of pain science.

Back to Top >

Neil O'Connell

Neil O’Connell, PhD, MSc, BSc (Hons)
Brunel University London, UK

Under Pressure: Lessons from and Beyond Entrapment Neuropathies

Annina Schmid, MSc, PhD, discusses why entrapment neuropathies—such as radiculopathies and carpal tunnel syndrome—are the most common cause of nerve injury and neuropathic pain. Drawing on well-phenotyped patient cohorts, she integrates cellular and molecular analyses of human biosamples with clinical assessments and advanced MR neurography to elucidate the neurobiological and psychosocial factors that shape divergent recovery trajectories and treatment responses. Schmid explores mechanistic insights that extend beyond classical neuropathic pain and asks whether embracing this complexity can enable more precise, personalised interventions for neuropathic pain.

Back to Top >

Annina Schmid, PhD, MManipTher
Oxford University, UK

Exercise Therapy for Chronic Pain: Basic Science and Clinical Practice

Emiko Senba, MD, PhD, explores why exercise is a powerful tool in chronic pain management from both scientific and clinical perspectives. She reviews how physical exercise influences the nervous system and can lead to long-term pain reduction (through mechanisms of exercise-induced hypoalgesia). The session also provides practical insights on integrating exercise programs into pain treatment plans to improve patient outcomes.

Back to Top >

Emiko Senba

Emiko Senba, MD, PhD
Osaka University, Japan

Advancing Equitable Pain Research and Care Globally

Saurab Sharma, PhD, addresses the challenges and opportunities of bringing high-value, evidence-based pain care to low- and middle-income countries (LMICs). Focusing on prevalent conditions like low back pain and musculoskeletal pain, he shares strategies for implementing effective treatments in resource-limited settings. The talk highlights global collaborations and health system innovations to improve pain outcomes for underserved populations worldwide.

Back to Top >

Saurab Sharma

Saurab Sharma, PhD
University of Sydney, Australia/Nepal

Reimagining Paediatric Pain Care: Toward a Mechanistic and Patient-Centered Future

Laura Simons, PhD, presents a vision for the future of pediatric pain management that merges scientific insight with patient-centered care. She reviews emerging mechanistic findings in pediatric pain and how they inform more effective, individualized treatments for children and adolescents. The talk highlights innovative approaches that empower young patients and their families in managing pain.

Back to Top >

Laura Simons

Laura Simons, PhD
Stanford University, USA

Spontaneous Neuropathic Pain

Clifford Woolf, MB, BCh, PhD, explores spontaneous neuropathic pain as a distinct and clinically significant component of neuropathic pain, separate from stimulus-evoked symptoms. Drawing on integrated molecular, cellular, and systems-level studies of painful neuromas in both humans and rodent models, he identifies key mechanistic drivers of spontaneous pain. This work reframes how neuropathic pain is understood and highlights new, mechanism-based therapeutic opportunities to address one of its most disabling features.

Back to Top >

Clifford Woolf, MB, BCh, PhD
Harvard University, USA